Pyrimidine or triazine fused bicyclic metalloprotease inhibitors

Details for Australian Patent Application No. 2006251989 (hide)

Owner Alantos-Pharmaceuticals, Inc.

Inventors Steeneck, Christoph; Essers, Michael; Deng, Hongbo; Sucholeiki, Irving; Nolte, Bert; Taveras, Arthur G.; Wu, Xinyuan; Gallagher, Brian; Kroth, Heiko; Boer, Jurgen; Feurstein, Tim; Gege, Christian; Powers, Timothy; Van Veldhuizen, Joshua; Hochguertel, Matthias; Schneider, Matthias; Bluhm, Harald; Kiely, Andrew; Richter, Frank

Agent Wrays

Pub. Number AU-B-2006251989

PCT Pub. Number WO2006/128184

Priority 60/734,991 09.11.05 US; 60/683,470 20.05.05 US; 60/706,465 08.08.05 US

Filing date 22 May 2006

Wipo publication date 30 November 2006

Acceptance publication date 27 May 2010

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 19/00 (2006.01) Drugs for skeletal disorders

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/128184 Priority application(s): WO2006/128184

27 May 2010 Application Accepted

  Published as AU-B-2006251989

23 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006251990-Intravascular cuff

2006251978-Selective apoptotic induction in cancer cells including activation of procaspase3